Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_assertion type Assertion NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_head.
- NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_assertion description "[Therefore, TAP expression restores both antigen presentation and immunogenicity in A375 melanoma cells and concomitantly increases IL-12 and IFN-gamma production in tumor antigen-specific CTLs; TAP should be considered as a part of the immunotherapies for MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_provenance.
- NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_assertion evidence source_evidence_literature NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_provenance.
- NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_assertion SIO_000772 18385764 NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_provenance.
- NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_assertion wasDerivedFrom befree-20150227 NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_provenance.
- NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_assertion wasGeneratedBy ECO_0000203 NP844593.RA0fMZp0YbpwbqGZcK40p9LELly2wGA7BViX3ERc6gRqA130_provenance.